Authors:
Schermuly, RT
Krupnik, E
Tenor, H
Schudt, C
Weissmann, N
Rose, F
Grimminger, F
Seeger, W
Walmrath, D
Ghofrani, HA
Citation: Rt. Schermuly et al., Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension - Maintenance of lung selectivity, AM J R CRIT, 164(9), 2001, pp. 1694-1700
Citation: A. Hatzelmann et C. Schudt, Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro, J PHARM EXP, 297(1), 2001, pp. 267-279
Authors:
Hidi, R
Timmermans, S
Liu, E
Schudt, C
Dent, G
Holgate, ST
Djukanovic, R
Citation: R. Hidi et al., Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis, EUR RESP J, 15(2), 2000, pp. 342-349
Authors:
Schermuly, RT
Roehl, A
Weissmann, N
Ghofrani, HA
Schudt, C
Tenor, H
Grimminger, F
Seeger, W
Walmrath, D
Citation: Rt. Schermuly et al., Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange, J PHARM EXP, 292(2), 2000, pp. 512-520
Authors:
Schermuly, RT
Ghofrani, HA
Enke, B
Weissmann, N
Grimminger, F
Seeger, W
Schudt, C
Walmrath, D
Citation: Rt. Schermuly et al., Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension, AM J R CRIT, 160(5), 1999, pp. 1500-1506